璉升科技(300051.SZ):眉山璉升光伏異質結電池片項目總共規劃8GW
格隆匯9月27日丨璉升科技(300051.SZ)近期在接待機構投資者調研時表示,上市公司璉升科技選定具有較高轉換效率、較高毛利率、良好市場前景的HJT光伏電池片作為新業務增長點,“眉山璉升光伏科技有限公司”繫上市公司璉升科技在丹稜縣設立的項目實施主體。
眉山璉升光伏異質結電池片項目總共規劃8GW,按8GW廠房一次性設計建設。總佔地387畝,廠房長535*190米,建築面積10.6萬平方米。預計建成後將是國內建築面積最大、單條生產線最長、單體產能最大的異質結電池片生產項目。從1月28日破土動工到8月22日首片下線,僅用206天。目前處於產能爬坡階段。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.